SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
19-Nov-24 6:45 PM View: | Piskel Kyle Chief Financial Officer | Adaptive Biotechnologies Corp (ADPT) | 18-Nov-24 | Sale | 248 | $4.98 | $1,235.04 | (< 1%) 154.58K to 154.33K | |
10-Oct-24 5:47 PM View: | Bobulsky Susan Chief Commercial Officer, MRD | Adaptive Biotechnologies Corp (ADPT) | 08-Oct-24 | Option Exercise | 5,000 | $1.98 | $9,900.00 | 2% 248.29K to 253.29K | |
23-Aug-24 4:27 PM View: | Taylor Stacy L SVP and General Counsel | Adaptive Biotechnologies Corp (ADPT) | 22-Aug-24 | Sale (Planned) | 26,922 | $4.50 | $121,079.00 | (16%) 166.29K to 139.37K | |
17-May-24 6:35 PM View: | Piskel Kyle Chief Financial Officer | Adaptive Biotechnologies Corp (ADPT) | 15-May-24 | Grant | 31,260 | -- | -- | 25% 123.32K to 154.58K | |
13-Mar-24 5:55 PM View: | Neupert Peter M Director | Adaptive Biotechnologies Corp (ADPT) | 12-Mar-24 | Option Exercise | 15,000 | $0.84 | $12,600.00 | 10% 154.3K to 169.3K | |
06-Mar-24 10:00 PM View: | Peterson Tycho Chief Financial Officer | Adaptive Biotechnologies Corp (ADPT) | 05-Mar-24 | Sale | 15,456 | $3.44 | $53,168.60 | (3%) 547.01K to 531.55K | |
06-Mar-24 10:00 PM View: | Lo Francis Chief People Officer | Adaptive Biotechnologies Corp (ADPT) | 05-Mar-24 | Sale | 14,700 | $3.43 | $50,439.10 | (5%) 270.94K to 256.25K | |
06-Mar-24 10:00 PM View: | Taylor Stacy L SVP and General Counsel | Adaptive Biotechnologies Corp (ADPT) | 05-Mar-24 | Sale | 13,381 | $3.43 | $45,962.90 | (7%) 179.67K to 166.29K | |
06-Mar-24 10:00 PM View: | Bobulsky Susan Chief Commercial Officer, MRD | Adaptive Biotechnologies Corp (ADPT) | 05-Mar-24 | Sale | 12,991 | $3.44 | $44,628.90 | (5%) 261.28K to 248.29K | |
06-Mar-24 10:00 PM View: | Piskel Kyle Principal Accounting Officer | Adaptive Biotechnologies Corp (ADPT) | 05-Mar-24 | Sale | 7,727 | $3.43 | $26,503.60 | (6%) 131.04K to 123.32K | |
06-Mar-24 10:00 PM View: | Benzeno Sharon Chief Commercial Ofc Imm Med | Adaptive Biotechnologies Corp (ADPT) | 05-Mar-24 | Sale | 29,390 | $3.44 | $100,994.00 | (8%) 356.81K to 327.42K | |
06-Mar-24 10:00 PM View: | Robins Chad M CEO and Chairman Director | Adaptive Biotechnologies Corp (ADPT) | 05-Mar-24 | Sale | 48,673 | $3.43 | $167,007.00 | (2%) 2.63M to 2.58M | |
06-Mar-24 10:00 PM View: | Rubinstein Julie President | Adaptive Biotechnologies Corp (ADPT) | 05-Mar-24 | Sale | 39,070 | $3.47 | $135,764.00 | (8%) 511.82K to 472.75K | |
06-Mar-24 10:00 PM View: | Lo Francis Chief People Officer | Adaptive Biotechnologies Corp (ADPT) | 04-Mar-24 | Grant | 99,976 | -- | -- | 58% 170.97K to 270.94K | |
06-Mar-24 10:00 PM View: | Taylor Stacy L SVP and General Counsel | Adaptive Biotechnologies Corp (ADPT) | 04-Mar-24 | Grant | 39,990 | -- | -- | 29% 139.68K to 179.67K | |
06-Mar-24 10:00 PM View: | Bobulsky Susan Chief Commercial Officer, MRD | Adaptive Biotechnologies Corp (ADPT) | 04-Mar-24 | Grant | 132,979 | -- | -- | 104% 128.3K to 261.28K | |
06-Mar-24 10:00 PM View: | Hershberg Robert Director | Adaptive Biotechnologies Corp (ADPT) | 04-Mar-24 | Grant | 31,328 | -- | -- | 41% 75.97K to 107.3K | |
06-Mar-24 10:00 PM View: | Benzeno Sharon Chief Commercial Ofc Imm Med | Adaptive Biotechnologies Corp (ADPT) | 04-Mar-24 | Grant | 132,979 | -- | -- | 59% 223.83K to 356.81K | |
06-Mar-24 10:00 PM View: | Robins Chad M CEO and Chairman Director | Adaptive Biotechnologies Corp (ADPT) | 04-Mar-24 | Grant | 354,610 | -- | -- | 16% 2.27M to 2.63M | |
06-Mar-24 10:00 PM View: | Robins Harlan S Chief Scientific Officer | Adaptive Biotechnologies Corp (ADPT) | 04-Mar-24 | Grant | 354,610 | -- | -- | 53% 666.57K to 1.02M | |
06-Mar-24 10:00 PM View: | Rubinstein Julie President | Adaptive Biotechnologies Corp (ADPT) | 04-Mar-24 | Grant | 175,000 | -- | -- | 52% 336.82K to 511.82K | |
06-Mar-24 10:00 PM View: | Peterson Tycho Chief Financial Officer | Adaptive Biotechnologies Corp (ADPT) | 04-Mar-24 | Grant | 147,790 | -- | -- | 37% 399.22K to 547.01K | |
06-Mar-24 10:00 PM View: | Burris Michelle Director | Adaptive Biotechnologies Corp (ADPT) | 04-Mar-24 | Grant | 31,328 | -- | -- | 152% 20.63K to 51.95K | |
06-Mar-24 10:00 PM View: | Neupert Peter M Director | Adaptive Biotechnologies Corp (ADPT) | 04-Mar-24 | Grant | 31,328 | -- | -- | 25% 122.97K to 154.3K | |
06-Mar-24 10:00 PM View: | Owen Katey Einterz Director | Adaptive Biotechnologies Corp (ADPT) | 04-Mar-24 | Grant | 31,328 | -- | -- | 121% 25.91K to 57.23K | |
06-Mar-24 10:00 PM View: | Piskel Kyle Principal Accounting Officer | Adaptive Biotechnologies Corp (ADPT) | 04-Mar-24 | Grant | 43,740 | -- | -- | 50% 87.31K to 131.04K | |
06-Mar-24 10:00 PM View: | Pellini Michael J Director | Adaptive Biotechnologies Corp (ADPT) | 04-Mar-24 | Grant | 31,328 | -- | -- | 136% 22.97K to 54.3K | |
15-Dec-23 4:21 PM View: | Neupert Peter M Director | Adaptive Biotechnologies Corp (ADPT) | 13-Dec-23 | Option Exercise | 100,000 | $0.84 | $84,000.00 | 435% 22.97K to 122.97K | |
20-Nov-23 10:00 PM View: | Piskel Kyle Principal Accounting Officer | Adaptive Biotechnologies Corp (ADPT) | 16-Nov-23 | Sale | 259 | $4.13 | $1,069.67 | (< 1%) 87.56K to 87.31K | |
08-Aug-23 4:53 PM View: | Sood Nitin Chief Commercial Officer, MRD | Adaptive Biotechnologies Corp (ADPT) | 08-Aug-23 | Sale (Planned) | 10,550 | $6.54 | $68,997.00 | (5%) 225.36K to 214.81K | |
08-Aug-23 4:53 PM View: | Sood Nitin Chief Commercial Officer, MRD | Adaptive Biotechnologies Corp (ADPT) | 07-Aug-23 | Sale | 5,652 | $6.78 | $38,320.60 | (2%) 231.01K to 225.36K | |
21-Jun-23 5:32 PM View: | Peterson Tycho Chief Financial Officer | Adaptive Biotechnologies Corp (ADPT) | 20-Jun-23 | Planned Option Sale | 134,961 | $8.14 | $1,098,580.00 | (25%) 534.18K to 399.22K | |
21-Jun-23 5:32 PM View: | Peterson Tycho Chief Financial Officer | Adaptive Biotechnologies Corp (ADPT) | 20-Jun-23 | Option Exercise | 134,961 | $7.30 | $985,215.00 | 34% 399.22K to 534.18K | |
06-Jun-23 4:23 PM View: | Peterson Tycho Chief Financial Officer | Adaptive Biotechnologies Corp (ADPT) | 02-Jun-23 | Sale | 38,000 | $7.16 | $272,080.00 | (8%) 492.89K to 454.89K | |
12-Apr-23 6:04 PM View: | Adams R Mark Chief Operating Officer | Adaptive Biotechnologies Corp (ADPT) | 11-Apr-23 | Sale (Planned) | 2,308 | $8.63 | $19,918.00 | (1%) 177.67K to 175.36K | |
12-Apr-23 6:04 PM View: | Adams R Mark Chief Operating Officer | Adaptive Biotechnologies Corp (ADPT) | 10-Apr-23 | Sale | 817 | $8.50 | $6,944.50 | (< 1%) 178.49K to 177.67K | |
29-Mar-23 5:01 PM View: | Burris Michelle Director | Adaptive Biotechnologies Corp (ADPT) | 27-Mar-23 | Sale (Planned) | 2,341 | $8.49 | $19,878.10 | (10%) 22.97K to 20.63K | |
08-Mar-23 8:03 PM View: | Adams R Mark Chief Operating Officer | Adaptive Biotechnologies Corp (ADPT) | 07-Mar-23 | Sale (Planned) | 17,155 | $8.60 | $147,533.00 | (9%) 195.64K to 178.49K | |
08-Mar-23 8:04 PM View: | Taylor Stacy L SVP and General Counsel | Adaptive Biotechnologies Corp (ADPT) | 07-Mar-23 | Sale (Planned) | 13,387 | $8.60 | $115,128.00 | (9%) 153.06K to 139.68K | |
08-Mar-23 8:01 PM View: | Sood Nitin Chief Commercial Officer, MRD | Adaptive Biotechnologies Corp (ADPT) | 07-Mar-23 | Sale (Planned) | 9,813 | $8.60 | $84,391.80 | (4%) 240.82K to 231.01K | |
08-Mar-23 8:03 PM View: | Adams R Mark Chief Operating Officer | Adaptive Biotechnologies Corp (ADPT) | 06-Mar-23 | Grant | 88,652 | -- | -- | 78% 113.52K to 202.17K | |
08-Mar-23 8:04 PM View: | Taylor Stacy L SVP and General Counsel | Adaptive Biotechnologies Corp (ADPT) | 06-Mar-23 | Grant | 85,697 | -- | -- | 118% 72.86K to 158.56K | |
08-Mar-23 8:03 PM View: | Adams R Mark Chief Operating Officer | Adaptive Biotechnologies Corp (ADPT) | 06-Mar-23 | Sale | 6,529 | $8.57 | $55,953.50 | (3%) 202.17K to 195.64K | |
08-Mar-23 8:01 PM View: | Sood Nitin Chief Commercial Officer, MRD | Adaptive Biotechnologies Corp (ADPT) | 06-Mar-23 | Grant | 132,979 | -- | -- | 116% 114.5K to 247.48K | |
08-Mar-23 8:06 PM View: | Burris Michelle Director | Adaptive Biotechnologies Corp (ADPT) | 06-Mar-23 | Grant | 14,775 | -- | -- | 180% 8.19K to 22.97K | |
08-Mar-23 8:02 PM View: | Benzeno Sharon Chief Commercial Ofc Imm Med | Adaptive Biotechnologies Corp (ADPT) | 06-Mar-23 | Sale | 11,749 | $8.57 | $100,689.00 | (5%) 235.57K to 223.83K | |
08-Mar-23 8:00 PM View: | Robins Chad M CEO and Chairman Director | Adaptive Biotechnologies Corp (ADPT) | 06-Mar-23 | Grant | 354,610 | -- | -- | 19% 1.92M to 2.27M | |
08-Mar-23 8:00 PM View: | Robins Harlan S Chief Scientific Officer | Adaptive Biotechnologies Corp (ADPT) | 06-Mar-23 | Grant | 354,610 | -- | -- | 114% 311.96K to 666.57K | |
08-Mar-23 8:01 PM View: | Rubinstein Julie President | Adaptive Biotechnologies Corp (ADPT) | 06-Mar-23 | Sale | 22,668 | $8.57 | $194,265.00 | (6%) 359.49K to 336.82K | |
08-Mar-23 8:03 PM View: | Peterson Tycho Chief Financial Officer | Adaptive Biotechnologies Corp (ADPT) | 06-Mar-23 | Grant | 118,203 | -- | -- | 32% 374.69K to 492.89K |